InvestSMART

Holista Colltech Limited (ASX:HCT)

ALERT: Price-sensitive ASX Announcement for HCT
Current share price for HCT : $0.080 0.015 (23.08%)+
Announcement
Release
28 Apr 2026 4:55PM
Price at Release
$0.065
Full Release
download
Summary
Holista Colltech Limited, an Australian company, reported its quarterly activities and cashflow for the period ending March 31, 2026. The company recorded a revenue of approximately $1.49 million, primarily driven by its Supplement segment, which maintained a revenue of $1.47 million. Cash receipts from customers totaled $1.31 million, while payments for operating activities were around $1.47 million, resulting in a net operating cash outflow. The company also dealt with a legal settlement regarding the ProImmune case, resolving a USD2.4 million judgement for USD1.8 million. Financing activities included a net cash outflow of $54,000, and cash and cash equivalents at the end of the period stood at $1.944 million. The report highlights ongoing efforts in product demand and legal resolutions, alongside stable financial management.
Key Points
  • Revenue of approximately $1.49 million recorded.
  • Supplement segment revenue maintained at $1.47 million.
  • Net operating cash outflow primarily due to inventory and legal fees.
  • Settlement with ProImmune for USD1.8 million.
  • Cash and cash equivalents at end of period: $1.944 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.